Search Results - Hailemichael, Yared

Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard by Hailemichael, Yared, Overwijk, Willem W

Get full text Get full text Get full text

Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination by Hailemichael, Yared, Overwijk, Willem W.

Get full text Get full text Get full text

MOUSE MODEL FOR PRE-CLINICAL STUDY OF HUMAN CANCER IMMUNOTHERAPY by Ya, Zhiya, Hailemichael, Yared, Overwijk, Willem, Restifo, Nicholas

Get full text Get full text Get full text

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model by Haymaker, Cara L., Hailemichael, Yared, Yang, Yi, Nurieva, Roza

Get full text Get full text Get full text

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy by Hailemichael, Yared, Fu, Tihui, Khong, Hiep, Dai, Zhimin, Sharma, Padmanee, Overwijk, Willem W

Get full text Get full text

Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways by Anthony, Scott M., Howard, Megan E., Hailemichael, Yared, Overwijk, Willem W., Schluns, Kimberly S.

Get full text Get full text Get full text

ANTI-TUMOR ACTIVITY MEDIATED BY CpG: THE ROUTE OF ADMINISTRATION IS CRITICAL by Lou, Yanyan, Liu, Chengwen, Lizée, Gregory, Peng, Weiyi, Xu, Chunyu, Ye, Yang, Rabinovich, Brian A., Hailemichael, Yared, Gelbard, Alexander, Zhou, Dapeng, Overwijk, Willem W., Hwu, Patrick

Get full text Get full text Get full text

Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy by Sikora, Andrew G., Gelbard, Alexander, Davies, Michael A., Sano, Daisuke, Ekmekcioglu, Suhendan, Kwon, John, Hailemichael, Yared, Jayaraman, Padmini, Myers, Jeffrey N., Grimm, Elizabeth A., Overwijk, Willem W.

Get full text Get full text Get full text

Interferon-α enhances peptide vaccine-induced CD8(+) T cell numbers, effector function, and anti-tumor activity by Sikora, Andrew G., Jaffarzad, Nina, Hailemichael, Yared, Gelbard, Alexander, Stonier, Spencer W., Schluns, Kimberly S., Frasca, Loredana, Lou, Yanyan, Liu, Chengwen, Andersson, Helen A., Hwu, Patrick, Overwijk, Willem W.

Get full text Get full text Get full text

Peptide vaccine formulation controls the duration of antigen presentation and magnitude of tumor-specific CD8+ T cell response by Khong, Hiep, Volmari, Annika, Sharma, Meenu, Dai, Zhimin, Imo, Chinonye S., Hailemichael, Yared, Singh, Manisha, Moore, Derek T., Xiao, Zhilan, Huang, Xue-fei, Horvath, Thomas D., Hawke, David H., Overwijk., Willem W.

Get full text Get full text Get full text

Tumor-expressed iNOS controls induction of functional myeloid derived suppressor cells (MDSC) through modulation of VEGF release() by Jayaraman, Padmini, Parikh, Falguni, Lopez-Rivera, Esther, Hailemichael, Yared, Clark, Amelia, Ma, Ge, Cannan, David, Ramacher, Marcel, Kato, Masashi, Overwijk, Willem W., Chen, Shu-Hsia, Umansky, Viktor Y., Sikora, Andrew G.

Get full text Get full text Get full text

Generation of a novel therapeutic peptide that depletes MDSC in tumor-bearing mice by Qin, Hong, Lerman, Beatrisa, Sakamaki, Ippei, Wei, Guowei, Cha, Soungchul, Rao, Sheetal S., Qian, Jianfei, Hailemichael, Yared, Nurieva, Roza, Dwyer, Karen C., Roth, Johannes, Yi, Qing, Overwijk, Willem W., Kwak, Larry W.

Get full text Get full text Get full text

Inhibition of p-STAT3 Enhances IFN-α Efficacy Against Metastatic Melanoma in a Murine Model by Kong, Ling-Yuan, Gelbard, Alexander, Wei, Jun, Reina-Ortiz, Chantal, Wang, Yongtao, Yang, Eric C., Hailemichael, Yared, Fokt, Izabela, Jayakumar, Arumugam, Qiao, Wei, Fuller, Gregory N., Overwijk, Willem W., Priebe, Waldemar, Heimberger, Amy B.

Get full text Get full text Get full text

Multifaceted role of BTLA in the control of CD8(+) T cell fate after antigen encounter by Ritthipichai, Krit, Haymaker, Cara L., Martinez, Melisa, Aschenbrenner, Andrew, Yi, Xiaohui, Zhang, Minying, Kale, Charuta, Vence, Luis M., Roszik, Jason, Hailemichael, Yared, Overwijk, Willem W., Varadarajan, Navin, Nurieva, Roza, Radvanyi, Laszlo G., Hwu, Patrick, Bernatchez, Chantale

Get full text Get full text Get full text

Absence of Grail promotes CD8(+) T cell anti-tumour activity by Haymaker, Cara, Yang, Yi, Wang, Junmei, Zou, Qiang, Sahoo, Anupama, Alekseev, Andrei, Singh, Divyendu, Ritthipichai, Krit, Hailemichael, Yared, Hoang, Oanh N., Qin, Hong, Schluns, Kimberly S., Wang, Tiejun, Overwijk, Willem W., Sun, Shao-Cong, Bernatchez, Chantale, Kwak, Larry W., Neelapu, Sattva S., Nurieva, Roza

Get full text Get full text Get full text

The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies. by Varghese, Sruthy, Pramanik, Snigdha, Williams, Leila J., Hodges, Hannah R., Hudgens, Courtney W., Fischer, Grant M., Luo, Catherine K., Knighton, Barbara, Tan, Lin, Lorenzi, Philip L., Mackinnon, Andrew L., McQuade, Jennifer L., Hailemichael, Yared, Roszik, Jason, Peng, Weiyi, Vashisht Gopal, Y. N.

Get full text Get full text Get full text

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion by Hailemichael, Yared, Dai, Zhimin, Jaffarzad, Nina, Ye, Yang, Medina, Miguel A, Huang, Xue-Fei, Dorta-Estremera, Stephanie M, Greeley, Nathaniel R, Nitti, Giovanni, Peng, Weiyi, Liu, Chengwen, Lou, Yanyan, Wang, Zhiqiang, Ma, Wencai, Rabinovich, Brian, Schluns, Kimberly S, Davis, Richard E, Hwu, Patrick, Overwijk, Willem W

Get full text Get full text Get full text

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain by Singh, Manisha, Vianden, Christina, Cantwell, Mark J., Dai, Zhimin, Xiao, Zhilan, Sharma, Meenu, Khong, Hiep, Jaiswal, Ashvin R., Faak, Faisal, Hailemichael, Yared, Janssen, L. M. E., Bharadwaj, Uddalak, Curran, Michael A., Diab, Adi, Bassett, Roland L., Tweardy, David J., Hwu, Patrick, Overwijk, Willem W.

Get full text Get full text Get full text

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy by Hailemichael, Yared, Woods, Amber, Fu, Tihui, He, Qiuming, Nielsen, Michael C., Hasan, Farah, Roszik, Jason, Xiao, Zhilan, Vianden, Christina, Khong, Hiep, Singh, Manisha, Sharma, Meenu, Faak, Faisal, Moore, Derek, Dai, Zhimin, Anthony, Scott M., Schluns, Kimberly S., Sharma, Padmanee, Engelhard, Victor H., Overwijk, Willem W.

Get full text Get full text Get full text

Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma by Zhang, Xiaohui, Lee, Hans C., Shirazi, Fazal, Baladandayuthapani, Veerabhadran, Lin, Heather, Kuiatse, Isere, Wang, Hua, Jones, Richard J., Berkova, Zuzana, Singh, Ram Kumar, Lu, Jing, Qian, Yimin, Raina, Kanak, Coleman, Kevin G., Crews, Craig M., Li, Bingzong, Wang, Huihan, Hailemichael, Yared, Thomas, Sheeba K., Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.

Get full text Get full text Get full text